Modulation of TTR Gene Expression in the Eye using Modified Duplex RNAs
Corey, D. R.; Hu, J.; Mootha, V.; Gong, X.; Egli, M.; Manoharan, M.; Kundu, J.; Corey, D.
Show abstract
Small interfering RNAs (siRNAs) are a proven therapeutic approach for controlling gene expression in the liver. Expanding the clinical potential of RNA interference (RNAi) requires developing strategies to enhance delivery to extra-hepatic tissues. In this study we examine inhibiting transthyretin (TRR) gene expression by short interfering RNAs (siRNAs) in the eye. Anti-TTR siRNAs have been developed as successful drugs to treat TTR amyloidosis. When administered systemically, anti-TTR siRNAs alleviate symptoms by blocking TTR expression in the liver. However, TTR amyloidosis also affects the eye, suggesting a need for reducing ocular TTR gene expression. Here, we demonstrate that C5 and 2-O-linked lipid-modified siRNAs formulated in saline can inhibit TTR expression in the eye when administered locally by intravitreal (IVT) injection. Modeling suggests that length and accessibility of the lipid chains contributes to in vivo silencing. GalNAc modified anti-dsRNAs also inhibit TTR expression, albeit less potently. These data support lipid modified siRNAs as an approach to treating the ocular consequences of TTR amyloidosis. Inhibition of TTR expression throughout the eye demonstrates that lipid-siRNA conjugates have the potential to be a versatile platform for ocular drug discovery. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=84 SRC="FIGDIR/small/642595v1_ufig1.gif" ALT="Figure 1"> View larger version (23K): org.highwire.dtl.DTLVardef@1e9ad27org.highwire.dtl.DTLVardef@67067borg.highwire.dtl.DTLVardef@1da7eadorg.highwire.dtl.DTLVardef@1b2a552_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- SETDB1 Triple Tudor Domain Ligand, (R,R)-59, Promotes Methylation of Akt1 in Cells 95%
- Design of an orally bioavailable small molecule that modulates the microtubule-associated protein tau's pre-mRNA splicing 95%
- A Novel Regioselective Approach to Cyclize Phage-Displayed Peptides in Combination with Epitope-Directed Selection to Identify a Potent Neutralizing Macrocyclic Peptide for SARS-CoV-2 94%
Similar papers in this journal
- Single intravitreal administration of a tetravalent siRNA exhibits robust and efficient gene silencing in rodent and swine photoreceptors 95%
- A Genome-wide CRISPR screen unveils the endosomal maturation protein WDR91 as a promoter of productive ASO activity in melanoma 93%
- A homodimeric aptamer variant generated from ligand-guided selection activates T-cell receptor cluster of differentiation three complex 93%
Similar papers in this journal
- Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease 95%
- Discovery of GS-5245 (Obeldesivir), an Oral Prodrug of Nucleoside GS-441524 that Exhibits Antiviral Efficacy in SARS-CoV-2 Infected African Green Monkeys 94%
- Development of potent and selective CK1α Molecular Glue Degraders 94%
Similar papers in this journal
- Overcoming Immune Checkpoint Inhibitor Resistance via Potent and Selective Dual αvβ6/8 Inhibitors Based on Engineered Lasso Peptides 95%
- Bioluminescence Imaging of Potassium Ion Using a Sensory Luciferin and an Engineered Luciferase 94%
- Engineering protease-resistant peptides to inhibit human parainfluenza viral respiratory infection 93%
Similar papers in this journal
- Novel approaches to label the surface of S. aureus with DBCO for click chemistry-mediated deposition of sensitive cargo 93%
- Discovery of membrane-permeating cyclic peptides via mRNA display 93%
- Piggybacking on the Cholera Toxin: Identification of a Toxoid-binding Protein as an Approach for Targeted Delivery of Proteins to Motor Neurons 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.